bradykinin, leu(8)-des-arg(9)- has been researched along with temocaprilat in 1 studies
| Studies (bradykinin, leu(8)-des-arg(9)-) | Trials (bradykinin, leu(8)-des-arg(9)-) | Recent Studies (post-2010) (bradykinin, leu(8)-des-arg(9)-) | Studies (temocaprilat) | Trials (temocaprilat) | Recent Studies (post-2010) (temocaprilat) |
|---|---|---|---|---|---|
| 102 | 0 | 7 | 29 | 4 | 1 |
| Protein | Taxonomy | bradykinin, leu(8)-des-arg(9)- (IC50) | temocaprilat (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, A; Maeda, K; Nakamura, M; Watanabe, T; Yasunari, K; Yoshikawa, J | 1 |
1 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and temocaprilat
| Article | Year |
|---|---|
Converting enzyme inhibitor temocaprilat prevents high glucose-mediated suppression of human aortic endothelial cell proliferation.
Topics: Alkaloids; Angiotensin-Converting Enzyme Inhibitors; Aorta; Benzophenanthridines; Bradykinin; Bradykinin B2 Receptor Antagonists; Cell Division; Cell Membrane; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endothelial Cells; Glucose; Humans; Naphthalenes; Oxidative Stress; Phenanthridines; Protein Kinase C; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Thiazepines; Time Factors | 2003 |